News & Events

Anders Tuv BioLeader Interview - Anders Tuv, Chief Investment Officer at Radforsk, Norway (May 2022) Anders is Chief Investment Officer of the life science investment company Radforsk, which is focused on immunotherapies and precision medicines. He is an experienced [...]

Agnete Fredriksen BioLeader Interview - Agnete Fredriksen, Co-Founder, Chief Innovation & Strategy Officer at Nykode Therapeutics AS (April 2022) Agnete is a co-founder of Nykode Therapeutics and served as Chief Scientific Officer from 2007-2021, leading the organisation’s scientific strategy. [...]

Camilla Simpson BioLeader Interview - Camilla Simpson, Chief Executive Officer, Zehna Therapeutics (April 2022) Camilla Simpson has over two decades of business and strategy experience across a diverse group of organizations: from seed investments to public companies. Camilla has [...]

Susan Hill BioLeader Interview - Susan Hill, Chief Executive Officer of Mestag Therapeutics and Venture Partner with SV Health Investors (February 2022) Susan Hill is founding Chief Executive Officer of Mestag Therapeutics, a Cambridge (UK)- based biotech company developing new therapeutics [...]